Form 8-K - Current report:
SEC Accession No. 0000950170-23-013199
Filing Date
2023-04-18
Accepted
2023-04-18 10:42:04
Documents
57
Period of Report
2023-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20230418.htm   iXBRL 8-K 55892
2 EX-99.1 rlay-ex99_1.htm EX-99 54066
3 EX-99.2 rlay-ex99_2.htm EX-99 53193
4 GRAPHIC img176012724_0.jpg GRAPHIC 291691
5 GRAPHIC rlay-ex99_1s1.jpg GRAPHIC 191088
6 GRAPHIC rlay-ex99_1s2.jpg GRAPHIC 730944
7 GRAPHIC rlay-ex99_1s3.jpg GRAPHIC 347319
8 GRAPHIC rlay-ex99_1s4.jpg GRAPHIC 346802
9 GRAPHIC rlay-ex99_1s5.jpg GRAPHIC 442938
10 GRAPHIC rlay-ex99_1s6.jpg GRAPHIC 278328
11 GRAPHIC rlay-ex99_1s7.jpg GRAPHIC 491953
12 GRAPHIC rlay-ex99_1s8.jpg GRAPHIC 458323
13 GRAPHIC rlay-ex99_1s9.jpg GRAPHIC 599918
14 GRAPHIC rlay-ex99_1s10.jpg GRAPHIC 385227
15 GRAPHIC rlay-ex99_1s11.jpg GRAPHIC 231333
16 GRAPHIC rlay-ex99_1s12.jpg GRAPHIC 379665
17 GRAPHIC rlay-ex99_1s13.jpg GRAPHIC 433302
18 GRAPHIC rlay-ex99_1s14.jpg GRAPHIC 432497
19 GRAPHIC rlay-ex99_1s15.jpg GRAPHIC 298479
20 GRAPHIC rlay-ex99_1s16.jpg GRAPHIC 460692
21 GRAPHIC rlay-ex99_1s17.jpg GRAPHIC 396448
22 GRAPHIC rlay-ex99_1s18.jpg GRAPHIC 346807
23 GRAPHIC rlay-ex99_1s19.jpg GRAPHIC 386249
24 GRAPHIC rlay-ex99_1s20.jpg GRAPHIC 391282
25 GRAPHIC rlay-ex99_1s21.jpg GRAPHIC 412139
26 GRAPHIC rlay-ex99_1s22.jpg GRAPHIC 298499
27 GRAPHIC rlay-ex99_1s23.jpg GRAPHIC 479637
28 GRAPHIC rlay-ex99_1s24.jpg GRAPHIC 367195
29 GRAPHIC rlay-ex99_1s25.jpg GRAPHIC 424649
30 GRAPHIC rlay-ex99_1s26.jpg GRAPHIC 393778
31 GRAPHIC rlay-ex99_1s27.jpg GRAPHIC 328511
32 GRAPHIC rlay-ex99_1s28.jpg GRAPHIC 479816
33 GRAPHIC rlay-ex99_1s29.jpg GRAPHIC 413218
34 GRAPHIC rlay-ex99_1s30.jpg GRAPHIC 286427
35 GRAPHIC rlay-ex99_1s31.jpg GRAPHIC 444771
36 GRAPHIC rlay-ex99_1s32.jpg GRAPHIC 329153
37 GRAPHIC rlay-ex99_1s33.jpg GRAPHIC 500973
38 GRAPHIC rlay-ex99_1s34.jpg GRAPHIC 374722
39 GRAPHIC rlay-ex99_1s35.jpg GRAPHIC 234660
40 GRAPHIC rlay-ex99_1s36.jpg GRAPHIC 385174
41 GRAPHIC rlay-ex99_1s37.jpg GRAPHIC 429702
42 GRAPHIC rlay-ex99_1s38.jpg GRAPHIC 383984
43 GRAPHIC rlay-ex99_1s39.jpg GRAPHIC 412596
44 GRAPHIC rlay-ex99_1s40.jpg GRAPHIC 117092
45 GRAPHIC rlay-ex99_1s41.jpg GRAPHIC 521739
46 GRAPHIC rlay-ex99_1s42.jpg GRAPHIC 344200
  Complete submission text file 0000950170-23-013199.txt   23281364

Data Files

Seq Description Document Type Size
47 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20230418.xsd EX-101.SCH 2454
48 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20230418_pre.xml EX-101.PRE 9890
49 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20230418_lab.xml EX-101.LAB 13474
51 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20230418_htm.xml XML 4754
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 23825825
SIC: 2836 Biological Products, (No Diagnostic Substances)